Frank McCaney


NB Therapeutics raising $1 million to fund nail fungus therapy

Nitric BioTheraputics, a biopharmaceutical and medical device company, is raising $1 million to fund clinical trials of its drug-delivery therapy for onychomycosis, a type of nail fungus, according to the CEO of the company, Frank McCaney. The company filed a Form D filing with the U.S. Securities and Exchange Commission dated Nov. 29. The┬áBristol, Pennsylvania […]